✦ LIBER ✦

Phase II clinical trial to evaluate the efficacy and safety of activated T-lymphocyte cell therapy in gemcitabine refractory advanced pancreatic cancer

✍ Scribed by Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; Song, Si Young

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Clinical Trial to Evaluate the

✍ Chung, Moon Jae ;Park, Jeong Youp ;Bang, Seungmin ;Park, Seung Woo ;Chung, Jae B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

An open, multi-centre, phase II clinical

✍ Chao, Y; Li, C P; Chao, T Y; Su, W C; Hsieh, R K; Wu, M F; Yeh, K H; Kao, W Y; C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

8702 ORAL A Phase II, Multicenter, Clini

✍ Matsutani, M.; Nishikawa, R.; Kobayashi, H.; Takano, S.; Shinoura, N.; Nagane, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A phase II, open-label, multicenter stud

✍ Li, D.; Pant, S.; Ryan, D.P.; Laheru, D.; Bahary, N.; Dragovich, T.; Hosein, P.J 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 222 KB

A phase II open-label randomized study t

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB

Erratum to: A phase II open-label random

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 61 KB